Results 141 to 150 of about 17,590 (203)

Efficacy and safety of CD19 combined with CD22 or CD20 chimeric antigen receptor T-cell therapy for hematological malignancies. [PDF]

open access: yesFront Immunol
Yuan X   +12 more
europepmc   +1 more source

Incidence of Bloodstream Infections in Pediatric Patients with Cancer during Febrile Neutropenia: A Retrospective Study. [PDF]

open access: yesJMA J
Matsukawa Y   +7 more
europepmc   +1 more source

Implementation of standard of care CAR-T-cell treatment for patients with aggressive B-cell lymphoma and acute lymphoblastic leukemia in Sweden. [PDF]

open access: yesLeukemia
Jerkeman M   +10 more
europepmc   +1 more source

Early T-cell Precursor Acute Lymphoblastic Leukemia/Lymphoma

open access: closedSurgical Pathology Clinics, 2013
Discrete diagnostic subtypes of T lymphoblastic leukemia/lymphoma (T-cell acute lymphoblastic leukemia/lymphoma, T-ALL) have historically not been widely recognized. Recently, a novel subset with distinctive immunophenotypic, molecular, and clinical features has been proposed.
David R. Czuchlewski, Kathryn Foucar
openalex   +4 more sources

Home - About - Disclaimer - Privacy